INFOSCUM.COM
Johnson & Johnson Suspends Vaccine Sales Guidance, Boosts Dividend; Stock Hits Record High - TheStreet
Published Date:
4/19/2022
Source:
news.google.com
Johnson & Johnson Suspends Vaccine Sales Guidance, Boosts Dividend; Stock Hits Record High
TheStreet
J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance
CNBC
Earnings: Johnson & Johnson misses on revenue, suspends vaccine sales guidance
Yahoo Finance
J&J suspends COVID-19 vaccine sales forecast
ABC News
Johnson & Johnson Beats Profit Estimates but Stock Dips on Guidance Cut
Barron's
View Full Coverage on Google News
Read the Full Story Here
InfoScum.com